Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Thyroid Gland01:23

The Thyroid Gland

The thyroid gland is a small, butterfly-shaped gland located in the neck and covers the anterior surface of the trachea. The gland has two lateral lobes connected by a thin tissue mass called the isthmus. Internally, each lobe comprises many small spherical structures known as thyroid follicles, surrounded by a network of blood vessels.
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

TSitologiia i genetika·2018
Same author

[Primary meningioma of the optical nerve sheet in infancy as initial presentation of neurofibromatosis type 2].

Der Pathologe·2018
Same author

[Update of the S2k guidelines : Surgical treatment of benign thyroid diseases].

Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen·2018
Same author

Methylation of L1RE1, RARB, and RASSF1 function as possible biomarkers for the differential diagnosis of lung cancer.

PloS one·2018
Same author

Proposal for an extended pTNM classification of thyroid carcinoma : Commentary on deficits of the 8th edition of the TNM classification.

Der Pathologe·2018
Same author

[Proposal for an extended pTNM classification of thyroid carcinoma : Commentary on deficits of the 8th edition of the TNM classification (German version)].

Der Pathologe·2018
Same journal

[Connective (tissue) pathology: What brings us together!]

Der Pathologe·2022
Same journal

[Giant cell-containing tumors of bone and differential diagnoses].

Der Pathologe·2022
Same journal

[Automation and application of robotics in the pathology laboratory].

Der Pathologe·2022
Same journal

[Practical diagnostic aspects of uterine leiomyosarcoma in the context of the 2020 WHO classification].

Der Pathologe·2022
Same journal

[Artificial intelligence: a solution for the lack of pathologists?]

Der Pathologe·2022
Same journal

[Predictive immunocytochemistry in non-small cell lung carcinoma].

Der Pathologe·2022
See all related articles

Related Experiment Video

Updated: Jun 6, 2026

Substernal Thyroid Biopsy Using Endobronchial Ultrasound-guided Transbronchial Needle Aspiration
10:19

Substernal Thyroid Biopsy Using Endobronchial Ultrasound-guided Transbronchial Needle Aspiration

Published on: November 10, 2014

[When is thyroid fine-needle biopsy most effective?].

K W Schmid1, C Reiners

  • 1Institut für Pathologie und Neuropathologie, Universitätsklinikum Essen, Universität Duisburg-Essen, Hufelandstr. 55, 45122, Essen, Deutschland. kw.schmid@uk-essen.de

Der Pathologe
|November 27, 2010
PubMed
Summary
This summary is machine-generated.

Standardizing thyroid nodule evaluation recommends fine-needle biopsy (FNB) for nodules >1 cm. However, in iodine-deficient Germany, FNB should be limited to cold nodules to avoid unnecessary procedures without improving cancer detection.

More Related Videos

Synchronous Triplanar Reconstruction Integrated with Color Doppler Mapping for Precise and Rapid Localization of Thyroid Lesions
05:41

Synchronous Triplanar Reconstruction Integrated with Color Doppler Mapping for Precise and Rapid Localization of Thyroid Lesions

Published on: February 9, 2024

Related Experiment Videos

Last Updated: Jun 6, 2026

Substernal Thyroid Biopsy Using Endobronchial Ultrasound-guided Transbronchial Needle Aspiration
10:19

Substernal Thyroid Biopsy Using Endobronchial Ultrasound-guided Transbronchial Needle Aspiration

Published on: November 10, 2014

Synchronous Triplanar Reconstruction Integrated with Color Doppler Mapping for Precise and Rapid Localization of Thyroid Lesions
05:41

Synchronous Triplanar Reconstruction Integrated with Color Doppler Mapping for Precise and Rapid Localization of Thyroid Lesions

Published on: February 9, 2024

Area of Science:

  • Endocrinology
  • Oncology
  • Diagnostic Imaging

Background:

  • Thyroid nodules are prevalent, affecting ~25% of adults in iodine-deficient regions like Germany.
  • European and American guidelines recommend fine-needle biopsy (FNB) for thyroid nodules >1 cm to detect occult thyroid cancer.
  • Current guidelines may lead to increased procedures without proportional benefits in specific populations.

Purpose of the Study:

  • To evaluate the impact of current European/American guidelines for thyroid nodule evaluation in iodine-deficient areas.
  • To determine if the recommended FNB threshold for all nodules >1 cm is appropriate for Germany.
  • To propose an optimized strategy for FNB in German thyroid nodule management.

Main Methods:

  • Retrospective analysis of thyroid nodule characteristics and biopsy outcomes.
  • Comparative analysis of cancer detection rates based on different FNB criteria.
  • Epidemiological data on thyroid nodule prevalence in iodine-deficient populations.

Main Results:

  • Applying the >1 cm FNB rule broadly in Germany would significantly increase FNB and surgical procedures.
  • This increase in procedures is unlikely to substantially improve the early detection rate of clinically significant thyroid carcinoma.
  • A high prevalence of nodules exists in Germany, necessitating a tailored approach.

Conclusions:

  • The universal recommendation for FNB in thyroid nodules >1 cm is not optimal for iodine-deficient regions like Germany.
  • Restricting FNB to hypofunctioning ("cold") nodules >1 cm is a more appropriate strategy for Germany.
  • This targeted approach aims to reduce unnecessary interventions while maintaining effective cancer detection.